ATXN1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.322760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.601800E-02
Normal-vs-Stage2
1.557770E-01
Normal-vs-Stage3
9.791700E-02
Normal-vs-Stage4
9.413800E-01
Stage1-vs-Stage2
3.286200E-01
Stage1-vs-Stage3
9.893000E-01
Stage1-vs-Stage4
7.294500E-02
Stage2-vs-Stage3
4.158800E-01
Stage2-vs-Stage4
7.902500E-02
Stage3-vs-Stage4
1.220200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.141360E-01
Normal-vs-AfricanAmerican
5.291200E-01
Normal-vs-Asian
1.069180E-01
Caucasian-vs-AfricanAmerican
1.983630E-01
Caucasian-vs-Asian
3.851800E-01
AfricanAmerican-vs-Asian
1.246820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.395640E-01
Normal-vs-Female
1.397550E-01
Male-vs-Female
5.793400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.996580E-01
Normal-vs-Age(41-60Yrs)
2.186800E-01
Normal-vs-Age(61-80Yrs)
1.235240E-01
Normal-vs-Age(81-100Yrs)
9.162400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.803800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.329400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.527000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.219900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.881900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.870000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.946400E-02
Normal-vs-Daily Drinker
2.120200E-02
Normal-vs-Weekly Drinker
2.508400E-01
Normal-vs-Occasional Drinker
1.936430E-01
Normal-vs-Social Drinker
4.318400E-01
Non Drinker-vs-Daily Drinker
3.395000E-01
Non Drinker-vs-Weekly Drinker
3.254000E-01
Non Drinker-vs-Occasional Drinker
4.188400E-01
Non Drinker-vs-Social Drinker
1.228980E-01
Daily Drinker-vs-Weekly Drinker
9.284300E-02
Daily Drinker-vs-Occasional Drinker
1.179950E-01
Daily Drinker-vs-Social Drinker
3.197800E-02
Weekly Drinker-vs-Occasional Drinker
8.396800E-01
Weekly Drinker-vs-Social Drinker
6.394800E-01
Occasional Drinker-vs-Social Drinker
4.851400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.348800E-01
Normal-vs-Grade 2
5.692300E-02
Normal-vs-Grade 3
1.504030E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.662800E-03
Grade 1-vs-Grade 3
5.175500E-02
Grade 1-vs-Grade 4
4.348800E-01
Grade 2-vs-Grade 3
5.136200E-01
Grade 2-vs-Grade 4
5.692300E-02
Grade 3-vs-Grade 4
1.504030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.507650E-01
Normal-vs-NonDiabetic
7.494200E-02
Diabetic-vs-NonDiabetic
6.330400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.694400E-02
Normal-vs-NoPancreatitis
1.167790E-01
Pancreatitis-vs-NoPancreatitis
5.593400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.119230E-01
Normal-vs-N1
1.636220E-01
N0-vs-N1
1.656610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.321230E-01
Normal-vs-TP53-NonMutant
8.129900E-02
TP53-Mutant-vs-TP53-NonMutant
5.617600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
